A new study on European Radiology considered patients with infiltrative non-measurable HCC and demonstrated a significant relationship between post-contrast tumor attenuation and therapeutic response after sorafenib; nevertheless, no significant change in terms of survival was recorded, due to the poor prognosis of selected patients.
Changes of post-contrast attenuation values on CT have a significant relationship with therapeutic response after sorafenib in patients with non-measurable infiltrative HCC
USER INFORMATION
Supported by an unrestricted
educational grant from
